Lupin acquires stake in Generic Health

Lupin acquires stake in Generic Health
Two molecules of Piramal get go ahead for clinical trials
Strides to focus on Australia, Asia markets
Venus to strengthen international presence
Fresenius Kabi to boost Dabur’s API business in India
Opto Circuits plans to invest Rs 80 crore
ACT commences clinical research services in US
Avesthagen signs MoU with ICMR
Indoco increasing product basket
Orchid to develop anti-coagulant drug from Merck
Zydus Cadila joins hands with WHO
Aurobindo gets US FDA nod for alendronate tabs
Event Brief
Piramal Group launches campaign against chronic diseases